eCART vs SimpleSense
The split is the ward against the patient's home. eCART scores hospital inpatients from RN-confirmed vitals already in the EHR, and the vendor reports a 13% relative mortality reduction since go-live at Yale. Nanowear sells a cloth garment worn at home, with cloud analytics on multi-sensor data and a cuffless blood pressure estimate. It holds four 510(k) clearances, the latest for SimpleSense-BP in December 2023.
The blood pressure estimate rests on a prospective multicentre study of 303 subjects over four weeks, internal to the company and written by Nanowear authors, who ask for external validation. No customers are named, no EHR is mentioned and the price is not public. Cardiology and heart failure programs running remote monitoring are who Nanowear is built for, and ward committees evaluating deterioration scoring are who eCART is built for.
Decision support · Reviewed November 2, 2026
eCART
by AgileMD
Early warning software that scores hospitalized ward patients for risk of deterioration from EHR data, for use by trained clinicians.
SimpleSense
by Nanowear · founded 2014
Cloth wearable with 510(k) cleared AI cloud analytics for remote cardiac monitoring and cuffless blood pressure.
When to pick each one
eCART
- Vendor-reported 13% lower mortality at Yale New Haven
- Scores from RN-confirmed vitals already in the EHR
SimpleSense
- Cloth garment for home heart failure monitoring
- Four 510(k) clearances, latest cuffless BP in 2023
- Cuffless blood pressure estimate from the garment
Score
Each row shows points earned of points available under the published rubric.
eCART
56of 100
SimpleSense
49of 100
| Dimension | eCART | SimpleSense | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 12 / 12 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 21 / 21 | 14.7 / 21 | +6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 4.5 / 9 | -4.5 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
eCART
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. There is no pricing page; the site offers a demo request only. |
SimpleSense
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
eCART
FDA decisions
K233253 (opens in new tab)510(k)2024-06-21
eCARTv5 Clinical Deterioration Suite (eCART)
Peer-reviewed
5 PubMed records name eCART.
- Early Warning Scores With and Without Artificial Intelligence. (opens in new tab)
- Multicenter Development and Prospective Validation of eCARTv5: A Gradient Boosted Machine Learning Early Warning Score. (opens in new tab)
- DETERIO-LLM: enhancing traditional deterioration risk scores with clinical context and advanced reasoning. (opens in new tab)
SimpleSense
FDA decisions
K232053 (opens in new tab)510(k)2023-12-08
SimpleSense-BP, SimpleSense-BP Software Application
K212160 (opens in new tab)510(k)2021-09-22
SimpleSENSE Platform
K201669 (opens in new tab)510(k)2020-11-06
SimpleSENSE
K161431 (opens in new tab)510(k)2016-11-30
SimplECG
Peer-reviewed
3 PubMed records name SimpleSense.
- Multiparametric cloth-based wearable, SimpleSense, estimates blood pressure. (opens in new tab)
- Development and Internal Validation of an AI-Enabled Cuff-less, Non-invasive Continuous Blood Pressure Monitor Across All Classes of Hypertension. (opens in new tab)
- Nanotechnology and Artificial Intelligence: An Emerging Paradigm for Postoperative Patient Care. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | eCART | SimpleSense |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2014 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.